Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard A Hansen

Showing results (1-10 of 140) with videos related to

Pageof 14
Sort By:
Research in Social & Administrative Pharmacy : RSAP|December 2, 2006
Methodological challenges surrounding direct-to-consumer advertising research--the measurement conundrumRichard A Hansen, Marcus Droege
Nature Reviews. Neurology|June 3, 2009
Are some antidepressants better than others?Gerald Gartlehner, Richard A Hansen
Research in Social & Administrative Pharmacy : RSAP|December 2, 2006
The study of direct-to-consumer advertising for prescription drugsJon C Schommer, Richard A Hansen
Expert Opinion on Drug Safety|April 28, 2017
Empirical estimation of under-reporting in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS)Yasser M Alatawi, Richard A Hansen
General Hospital Psychiatry|January 28, 2014
Prevalence of depressive symptoms and predictors of treatment among U.S. adults from 2005 to 2010Saranrat Wittayanukorn, Jingjing Qian, Richard A Hansen
Psychological Services|August 15, 2017
Patterns of psychiatric emergency department utilization among community-dwelling Medicare beneficiaries under 65Jingjing Qian, Saranrat Wittayanukorn, Richard A Hansen
Journal of Clinical Pharmacy and Therapeutics|April 8, 2021
Understanding authorized generics-A review of the published clinical dataJustine Alderfer, Richard A Hansen, T Joseph Mattingly
Journal of Managed Care & Specialty Pharmacy|June 29, 2018
Serious Adverse Drug Events Reported to the FDA: Analysis of the FDA Adverse Event Reporting System 2006-2014 DatabaseKalyani B Sonawane, Ning Cheng, Richard A Hansen
Expert Opinion on Drug Safety|July 28, 2018
Does public perception bias lead to more frequent reporting of adverse events: branded vs generic drugsJingjing Qian, Ahmed Ullah Mishuk, Richard A Hansen
Clinical Therapeutics|December 20, 2014
Utilization patterns of antihypertensive drugs among the chronic kidney disease population in the United States: a cross-sectional analysis of the national health and nutrition examination surveyKalyani B Sonawane, Jingjing Qian, Richard A Hansen
Pageof 14

Showing results (1-10 of 140) with videos related to

Sort By:
Pageof 14
Research in Social & Administrative Pharmacy : RSAP|December 2, 2006
Methodological challenges surrounding direct-to-consumer advertising research--the measurement conundrumRichard A Hansen, Marcus Droege
Nature Reviews. Neurology|June 3, 2009
Are some antidepressants better than others?Gerald Gartlehner, Richard A Hansen
Research in Social & Administrative Pharmacy : RSAP|December 2, 2006
The study of direct-to-consumer advertising for prescription drugsJon C Schommer, Richard A Hansen
Expert Opinion on Drug Safety|April 28, 2017
Empirical estimation of under-reporting in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS)Yasser M Alatawi, Richard A Hansen
General Hospital Psychiatry|January 28, 2014
Prevalence of depressive symptoms and predictors of treatment among U.S. adults from 2005 to 2010Saranrat Wittayanukorn, Jingjing Qian, Richard A Hansen
Psychological Services|August 15, 2017
Patterns of psychiatric emergency department utilization among community-dwelling Medicare beneficiaries under 65Jingjing Qian, Saranrat Wittayanukorn, Richard A Hansen
Journal of Clinical Pharmacy and Therapeutics|April 8, 2021
Understanding authorized generics-A review of the published clinical dataJustine Alderfer, Richard A Hansen, T Joseph Mattingly
Journal of Managed Care & Specialty Pharmacy|June 29, 2018
Serious Adverse Drug Events Reported to the FDA: Analysis of the FDA Adverse Event Reporting System 2006-2014 DatabaseKalyani B Sonawane, Ning Cheng, Richard A Hansen
Expert Opinion on Drug Safety|July 28, 2018
Does public perception bias lead to more frequent reporting of adverse events: branded vs generic drugsJingjing Qian, Ahmed Ullah Mishuk, Richard A Hansen
Clinical Therapeutics|December 20, 2014
Utilization patterns of antihypertensive drugs among the chronic kidney disease population in the United States: a cross-sectional analysis of the national health and nutrition examination surveyKalyani B Sonawane, Jingjing Qian, Richard A Hansen
Pageof 14